We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ACR market cap is 12.5M. The company's latest EPS is AUD -0.0200 and P/E is -2.00.
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 1.4M | 5.12M | 5.09M | 11.81M | 7.96M |
Operating Income | -11.93M | -12.47M | -9.6M | -334k | -5.7M |
Net Income | -9.47M | -12.63M | -9.83M | -764k | -5.8M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 17.84M | 23.33M | 14.3M | 13.29M | 8.96M |
Total Liabilities | 4.99M | 4.86M | 5.21M | 4.59M | 5.69M |
Total Equity | 12.85M | 18.47M | 9.09M | 8.7M | 3.28M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -8.53M | -11.41M | -8.82M | 703k | -4.3M |
Investing | -254k | -102k | -465k | -119k | -276k |
Financing | -159k | 17.58M | -155k | -183k | 1.29M |
Market Cap | 12.5M |
Price to Earnings Ratio | -2.00 |
Price to Sales Ratio | 1.46 |
Price to Cash Ratio | 3.96 |
Price to Book Ratio | 3.55 |
Dividend Yield | - |
Shares Outstanding | 290.72M |
Average Volume (1 week) | 75.94k |
Average Volume (1 Month) | 141.79k |
52 Week Change | -2.27% |
52 Week High | 0.099 |
52 Week Low | 0.042 |
Spread (Intraday) | 0 (2.27%) |
Company Name | Acrux Limited |
Address |
103-113 stanley street melbourne, victoria 3003 |
Website | https://www.acrux.com.au |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions